190 related articles for article (PubMed ID: 32767939)
21. Herbal Medicine for Glioblastoma: Current and Future Prospects.
Khan I; Mahfooz S; Hatiboglu MA
Med Chem; 2020; 16(8):1022-1043. PubMed ID: 32000653
[TBL] [Abstract][Full Text] [Related]
22. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
23. Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway.
Ham SW; Kim JK; Jeon HY; Kim EJ; Jin X; Eun K; Park CG; Lee SY; Seo S; Kim JY; Choi SH; Hong N; Lee YY; Kim H
J Ethnopharmacol; 2019 May; 236():393-400. PubMed ID: 30878548
[TBL] [Abstract][Full Text] [Related]
24. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
25. The involvement of mitochondrial apoptotic pathway in eugenol-induced cell death in human glioblastoma cells.
Liang WZ; Chou CT; Hsu SS; Liao WC; Shieh P; Kuo DH; Tseng HW; Kuo CC; Jan CR
Toxicol Lett; 2015 Jan; 232(1):122-32. PubMed ID: 25455450
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
27. Emerging therapeutic targets and agents for glioblastoma migrating cells.
Di C; Mattox AK; Harward S; Adamson C
Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259
[TBL] [Abstract][Full Text] [Related]
28. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
29. Case-specific potentiation of glioblastoma drugs by pterostilbene.
Schmidt L; Baskaran S; Johansson P; Padhan N; Matuszewski D; Green LC; Elfineh L; Wee S; Häggblad M; Martens U; Westermark B; Forsberg-Nilsson K; Uhrbom L; Claesson-Welsh L; Andäng M; Sintorn IM; Lundgren B; Lönnstedt I; Krona C; Nelander S
Oncotarget; 2016 Nov; 7(45):73200-73215. PubMed ID: 27689322
[TBL] [Abstract][Full Text] [Related]
30. Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme.
Tagde P; Tagde P; Tagde S; Bhattacharya T; Garg V; Akter R; Rahman MH; Najda A; Albadrani GM; Sayed AA; Akhtar MF; Saleem A; Altyar AE; Kaushik D; Abdel-Daim MM
Biomed Pharmacother; 2021 Sep; 141():111928. PubMed ID: 34323701
[TBL] [Abstract][Full Text] [Related]
31. Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme.
Desai V; Bhushan A
Biomed Res Int; 2017; 2017():9363040. PubMed ID: 29359162
[TBL] [Abstract][Full Text] [Related]
32. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
33. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
[TBL] [Abstract][Full Text] [Related]
34. GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme.
Hasanpour Segherlou Z; Nouri-Vaskeh M; Noroozi Guilandehi S; Baghbanzadeh A; Zand R; Baradaran B; Zarei M
J Cell Physiol; 2021 Aug; 236(8):5564-5581. PubMed ID: 33580506
[TBL] [Abstract][Full Text] [Related]
35. Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.
Kratzsch T; Kuhn SA; Joedicke A; Hanisch UK; Vajkoczy P; Hoffmann J; Fichtner I
J Cancer Res Clin Oncol; 2018 May; 144(5):809-819. PubMed ID: 29427211
[TBL] [Abstract][Full Text] [Related]
36. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
37. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
[TBL] [Abstract][Full Text] [Related]
38. Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells.
Andreoli Miyake J; Nascimento Gomes R; Colquhoun A
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106452. PubMed ID: 32439412
[TBL] [Abstract][Full Text] [Related]
39. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme.
Lv L; Zheng L; Dong D; Xu L; Yin L; Xu Y; Qi Y; Han X; Peng J
Food Chem Toxicol; 2013 Sep; 59():657-69. PubMed ID: 23871826
[TBL] [Abstract][Full Text] [Related]
40. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
